HARBOURVEST PARTNERS LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$485,000
-19.7%
440,6270.0%0.18%
-31.2%
Q2 2020$604,000
+20.3%
440,6270.0%0.26%
+7.4%
Q1 2020$502,000
-50.0%
440,6270.0%0.24%
-41.5%
Q4 2019$1,005,000
+170.2%
440,6270.0%0.41%
+167.1%
Q3 2019$372,000
-56.7%
440,627
-50.0%
0.16%
-3.7%
Q2 2019$860,000
+55.0%
881,254
+100.0%
0.16%
-17.9%
Q1 2019$555,000
-61.1%
440,6270.0%0.20%
-71.0%
Q4 2018$1,428,000
+34.5%
440,6270.0%0.68%
-29.5%
Q3 2018$1,062,000
-13.6%
440,6270.0%0.96%
-38.1%
Q2 2018$1,229,000
-41.3%
440,6270.0%1.55%
-31.1%
Q1 2018$2,093,000
-18.5%
440,6270.0%2.25%
+8.8%
Q4 2017$2,569,000
+177.7%
440,6270.0%2.07%
+239.3%
Q3 2017$925,000
-55.1%
440,6270.0%0.61%
-31.3%
Q2 2017$2,062,000
-40.2%
440,6270.0%0.89%
-53.9%
Q1 2017$3,446,000440,6271.93%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,804,027$17,803,0002.95%
HARBOURVEST PARTNERS LLC 440,627$2,062,0000.89%
NEA Management Company, LLC 3,556,778$16,646,0000.61%
Rock Springs Capital Management LP 450,000$2,106,0000.11%
Bain Capital Public Equity Management, LLC 263,498$1,233,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 65,973$309,0000.06%
Hillhouse Capital Management 865,923$4,053,0000.06%
SABBY MANAGEMENT, LLC 125,151$586,0000.04%
Marshall Wace North America L.P. 684,124$3,421,0000.02%
FNY Partners Fund LP 20,127$94,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders